Advertisement
Advertisement
CCCC
C4 Therapeutics, Inc.
3.00
USDSponsored
-0.15
-4.76%
Nov 10, 15:59 UTC -5
Closed
After-Market
3.03
+0.03
+1.13%
C4 Therapeutics, Inc. (CCCC)
C4 Therapeutics, Inc. Financial Snapshot
| Market Cap | 398.42M |
| Beta | 3.16 |
| Earnings Per Share (EPS) | -0.72 |
| Price-to-Book (P/B) Ratio | 1.40 |
| Operating Margin | -289.44% |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -45.45% |
| Current Ratio | 5.17% |
| Free Cash Flow | -57.59M |
